Swiss National Bank raised its stake in Ingevity Corp (NASDAQ:NGVT) by 2.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 70,590 shares of the company’s stock after buying an additional 1,400 shares during the quarter. Swiss National Bank owned about 0.17% of Ingevity Corp worth $4,052,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. BlackRock Inc. lifted its position in Ingevity Corp by 90,224.0% in the first quarter. BlackRock Inc. now owns 5,089,759 shares of the company’s stock valued at $309,712,000 after buying an additional 5,084,124 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Ingevity Corp by 1.0% during the first quarter. Vanguard Group Inc. now owns 3,772,263 shares of the company’s stock worth $229,543,000 after purchasing an additional 37,842 shares in the last quarter. State Street Corp lifted its position in shares of Ingevity Corp by 5.2% during the first quarter. State Street Corp now owns 1,087,471 shares of the company’s stock worth $66,168,000 after purchasing an additional 53,998 shares in the last quarter. Channing Capital Management LLC lifted its position in shares of Ingevity Corp by 8.4% during the second quarter. Channing Capital Management LLC now owns 901,830 shares of the company’s stock worth $51,765,000 after purchasing an additional 70,130 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of Ingevity Corp by 1.8% during the first quarter. Bank of New York Mellon Corp now owns 657,706 shares of the company’s stock worth $40,021,000 after purchasing an additional 11,628 shares in the last quarter.

Shares of Ingevity Corp (NASDAQ:NGVT) opened at 61.82 on Friday. The firm has a market cap of $2.61 billion and a PE ratio of 49.38. Ingevity Corp has a one year low of $40.24 and a one year high of $62.00. The company has a 50-day moving average of $59.86 and a 200 day moving average of $59.86.

Ingevity Corp (NASDAQ:NGVT) last released its quarterly earnings results on Wednesday, August 2nd. The company reported $0.78 EPS for the quarter, topping the consensus estimate of $0.70 by $0.08. The firm had revenue of $260.30 million for the quarter, compared to analyst estimates of $259.56 million. Ingevity Corp had a return on equity of 76.78% and a net margin of 13.75%. The firm’s revenue for the quarter was up 2.3% compared to the same quarter last year. On average, equities research analysts expect that Ingevity Corp will post $2.40 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Ingevity Corp (NGVT) Holdings Lifted by Swiss National Bank” was first published by Daily Political and is the property of of Daily Political. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://www.dailypolitical.com/2017/09/24/ingevity-corp-ngvt-holdings-lifted-by-swiss-national-bank.html.

Several analysts have recently issued reports on NGVT shares. Aegis reissued a “buy” rating and set a $67.00 price target on shares of Ingevity Corp in a research report on Tuesday, July 4th. Zacks Investment Research raised shares of Ingevity Corp from a “hold” rating to a “buy” rating and set a $64.00 price target on the stock in a research report on Wednesday, July 5th. Jefferies Group LLC set a $68.00 price target on shares of Ingevity Corp and gave the stock a “buy” rating in a research report on Wednesday, July 5th. KeyCorp reissued a “buy” rating and set a $70.00 price target on shares of Ingevity Corp in a research report on Friday, September 8th. Finally, BidaskClub cut shares of Ingevity Corp from a “sell” rating to a “strong sell” rating in a research report on Friday, September 15th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $66.40.

Ingevity Corp Company Profile

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals.

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corp (NASDAQ:NGVT).

Institutional Ownership by Quarter for Ingevity Corp (NASDAQ:NGVT)

Receive News & Ratings for Ingevity Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corp and related companies with MarketBeat.com's FREE daily email newsletter.